PDS Biotechnology Corporation (NASDAQ:PDSB) Q1 2026 Earnings Call Transcript May 13, 2026
PDS Biotechnology Corporation beats earnings expectations. Reported EPS is $-0.13, expectations were $-0.15.
Operator: Greetings, and welcome to the PDS Biotech First Quarter 2026 Earnings Conference Call. [Operator Instructions] It is now my pleasure to introduce your host, [ Dean Schwartz ]. Thank you. You may begin.
Unknown Attendee: Thank you, operator. Good morning, everyone, and welcome to PDS...
